Multiple system atrophy (MSA) is a rare disorder with limited treatment options. However, recent research has yielded encouraging insights into new therapeutic approaches. Current focus centers on targeting the underlying pathophysiology of MSA. One approach under investigation involves drug-based interventions to influence the function of specifi